戻る
Alps Group Inc (GLLIR)価格
GLLIR 株価推移チャート
GLLIR 収入
Alps Group Inc
$0.26
13.04%
$0.03
終値： Jan 20, 16:00:00 GMT-5
$0
-100%
$-0.26
プレマーケット： Jan 21, 07:37:22 GMT-5
主要データ
前終値
$0.23
始値
$0.221
当日レンジ
-
52週レンジ
-
取引高
120.4K
平均取引高
415.6K
1株当たり利益(TTM)
-0.51
配当利回り
--
時価総額
--
GLLIRとは何ですか？
Alps Group Inc is a MY-based company operating in Biotechnology industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.